Parul Institute of Pharmacy

Dr. Deepa H. Patel

Designation : Associate Professor
Total Exp : 9.5 years
Educational Qualification : M. Pharm, Ph.D
Research Area :
The primary focus is developing and translating new drug delivery technologies for the prevention and treatment various diseases such as Cancer, HIV and Asthma.
Dr. Deepa Patel is enthusiastic academician and an active researcher in field of Pharmaceutical Technology (GATE qualified). Her research interests primarily focus on developing and translating new drug delivery systems for the prevention and treatment various diseases such as Cancer, HIV and Asthma. She has a special interest in inter-disciplinary research and project with industries and other academic Institutes. She has published 09 research papers in high Impact factor journals. She has filed 05 Indian patent applications in field of Novel Drug Delivery Systems and published 03 International book chapters to her credit. Currently she is working on a funded research project approved by Gujarat Council on Science and Technology (GUJCOST), Gandhinagar. She presented her research paper in 06 international conferences (organized in USA and Canada). She has guided 30 post-graduate students. She has been awarded International conference grant from ICMR and travel grant from Department of Science and technology (DST) and Department of Biotechnology (DBT). She got “Scholar In Training Award” (2000$) from American Association for Cancer Research (AACR), USA for best paper. Currently, She is working as an Associate Professor in Pharmaceutics Department, Faculty of Pharmacy, Parul University. Along with her teaching duties, she serves as an Instrument and Chemical In charge, NBA coordinator and Time Table coordinator duties. She has 7 h-index and 188 citation in scopus and 6 h-index and 227 citation in Google Scholar.
Contact Information
Office Phone-
Email[email protected]
Specialization AreasPharmaceutical Technology and Novel Drug delivery Systems

International Journal Papers

[1]Intranasal Delivery of Cyclobenzaprine hydrochloride loaded thiolated chitosan nanoparticles for pain relief, Journal of Drug Targeting, 2013 Sep; 21(8):759-69.

[2]In vitro Mechanistic study of cell death and in vivo performance evaluation of RGD grafted PEGylated Docetaxel liposomes in breast cancer, Nanomedicine: Nanotechnology, Biology and Medicine, 2012 Aug;8(6):951-62, doi:10.1016/j.nano.2011.11.008.

[3]Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain, Journal of Pharmaceutical Sciences, 101(2), 690-706, 2012. ( DOI: 10.1002/jps.22780).

[4]Simultaneous determination of lamivudine/zidovudine/nevirapine in humal plasma using RP-HPLC, Journal of Pharmacy Research, 2010, 3(9), 2322-2324.

[5]Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology, Journal of supercritical fluids, 54 (2010) 110–119.

[6]Simultaneous Determination of Atorvastatin Calcium and Ezetimib by Ratio Spectra Derivative Spectrophotometry and Reverse Phase-High Performance Liquid Chromatography, Asian J. Chem., Vol. 22, pp. 2511-2517 (2010.)

[7]Recent advances in liposomal dry powder formulations: preparation and evaluation, Expert Opinion on Drug Delivery January 2009, Vol. 6, No. 1, Pages 71-89.

[8]Review Article of “Self Micro-Emulsifying Drug Delivery System: Formulation Development and biopharmaceutical Evaluation of Lipophilic drugs, Current Drug Delivery, Volume 6, Number 4, August 2009 , pp. 419-424(6).

[9]Oral Bioavailability Enhancement of Acyclovir by Self Micro-Emulsifying Drug Delivery Systems (SMEDDS), Drug Development and Industrial Pharmacy,   December 2007; 33:12, 1318-1326.

International  Conference Papers

[1]Paper presentation entitled “Intranasal Administration of Tizanidine HCl loaded Trimethyl Chitosan Nanoparticles for the Alleviation of Pain” by the conference of The 39th Annual Meeting & Exposition of the Controlled Release Society” on July 15-18, 2012 at Quebec, Canada.

[2]Paper presentation entitled “Improved In vitro Efficacy study of RGDfk Conjugated Docetaxel Encapsulated Solid Lipid Nanoparticles on Breast Cancer Cells” by American Association of cancer research, AACR conference of 102nd AACR Annual meeting on 2-6  April, 2011 at Orlando, FL.

[3]Paper presentation of Preparation and brain uptake studies of Tizanidine HCl after Intranasal delivery of thiolated chitosan nanoparticles in NANO DDS conference at Omaha, Nebraska, USA on 3-5th October 2010.

[4]Paper presentation entitled “RGD grafted Docetexal encapsulated PLGA nanoparticles for breast cancer therapy: by American Association of cancer research” AACR conference of  101st AACR Annual meeting on 17-21st April, 2010 at Washington DC, USA.

[5]Paper presentation entitled “Mechanistic study of cell death on Breast cancer cells by Docetaxel encapsulated RGDfK Grafted Liposomes formulation” by American Association of cancer research, AACR conference of “Cell death mechanism and cancer therapy” Feb 2010, San diago, USA.

[6]Paper presentation of Preparation and Evaluation of Pioglitazone Microemulsion for Intranasal delivery in Alzheimer’s disease in Controlled Release Society, Hilton New York, New York, NY U.S.A on 12th to 16th July 2008.

National  Conference Papers:

[1]Paper presentation of Preparation and Evaluation of Pioglitazone Microemulsion for Intranasal delivery in Alzheimer’s disease in 59th Indian Pharmaceutical Congress, Varanasi, December 21-24, 2007.

[2]Paper presentation of Development of Self-Microemulsifying Drug Delivery Systems (SMEDDS) for Oral Bioavailability Enhancement of Saquinavir has been accepted in International conference of Controlled Release Society 34th Annual Meeting & Exposition to be held at Long beach, California during July 7-11, 2007.

[3]Paper presentation of Development, Formulation and In vitro Evaluation of Topical Antiageing Preparation of the Fruit of Benincasa Hispida in 58th Indian Pharmaceutical Congress, Mumbai, December 1-3, 2006.

[4]Paper presentation of Self Micro-Emulsifying Drug Delivery System (SMEDDS) for improving oral Bioavailability of Acyclovir in 58th Indian Pharmaceutical Congress, Mumbai, December 1-3, 2006.


[1]Chapter 5 “Gene Delivery Using Viral Vectors” Challenges in Delivery of Therapeutic Genomics and Proteomics in Elsevier, USA, First edition 2011.

[2]Chapter 6 “Application of polymer in peyer’s patch targeting” Application of polymer in Drug Delivery, in Smithers Rapra, 2014, ISBN: 9781847358516, Shawbury, Shrewsbury, Shropshire, SY4 4NR.

[3]Chapter 1 ” Introduction- Biointeration of Nanomaterials: Challenges and Solution,  CRC Paress, Talor & Fransis, USA, 2014

Fund Type Agency Start Date Duration Investigators
Research Grant GUJCOST 28/03/2016 2 Years Dr. Deepa Patel

[1]Indian patent application” Development and Evaluation of Amino Acid Based Lyophilized Dry Powder Inhalers of Theophylline and Montelukast for Treatment of Asthma” 3664/MUM/2014, dated 19/11/2014.

[2]Indian patent application” Fabrication of Biodegradable Vaginal Ring for Combine Contraceptive Therapy of Ethinyl Estradiol and Levonorgestrel” 3984/MUM/2013 dated 19/12/2013.

[3]Indian patent application “Dry Powder Inhaler of Salbutamol Sulphate and Fluticasone Propionate Combination. #3246/MUM/2011dated 18.11.2011.

[4]Indian patent application, Topical Gel of Adapalene and Azithromycin Combination 4/MUM/2012, Date: 02/01/2012.

[5]Indian patent application, Preparation of Solid Lipid Nanoparticles by Supercritical Fluid technology, Application no. 390/MUM/2008, Date: 25/02/2008.